Ceftazidime and Nitroglycerin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ceftazidime (ceftazidime) and Nitroglycerin (nitroglycerin). Common drug interactions include abdominal pain upper among females and pneumonia among males.
The phase IV clinical study analyzes what interactions people have when they take Ceftazidime and Nitroglycerin. It is created by eHealthMe based on reports of 90 people who take the same drugs from the FDA, and is updated regularly.
What is Ceftazidime?
Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.
What is Nitroglycerin?
Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.
90 people who take Ceftazidime and Nitroglycerin together, and have interactions are studied.

What are the common drug interactions of Ceftazidime and Nitroglycerin, by gender? *:
female:
- Abdominal pain upper
- Cardiomegaly (increased size of heart than normal)
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Cough
- Headache (pain in head)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Pyrexia (fever)
- Rhinorrhoea (watery mucus discharge from the nose)
- Anaemia (lack of blood)
- Aortic calcification (aortic calcification sign of heart valve disease)
male:
- Pneumonia
- Cardiac failure
- Multi-organ failure (multisystem organ failure)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Diarrhoea
- Blood bilirubin increased
- Blood urea increased
- Cellulitis (infection under the skin)
- Fatigue (feeling of tiredness)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
What are the common drug interactions of Ceftazidime and Nitroglycerin, by age (0-1 to 60+)? *:
0-1:
- Thrombocytopenia (decrease of platelets in blood)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
2-9:
n/a
10-19:
n/a
20-29:
- Renal failure (kidney dysfunction)
- Blood creatine phosphokinase increased
- Cardiac failure
- Myoglobin blood increased (presence of myoglobin in blood increased)
- Post procedural haemorrhage (post procedural bleeding)
- Pulmonary haemorrhage (acute bleeding from the lung)
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
- Troponin i increased
- Abdominal pain upper
30-39:
- Arrhythmia (irregular heartbeat)
- Cardiac failure
- Chronic kidney disease
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Renal failure (kidney dysfunction)
40-49:
- Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
- Haemoglobin decreased
- Peritonsillar abscess (painful pus filled inflammation of the tonsils and surrounding tissues)
- Pyrexia (fever)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Bradycardia (abnormally slow heart action)
- Cardiac arrest
- Cardiac flutter (abnormal heart rhythm)
- Haemorrhage intracranial (bleeding within the skull)
- Hypotension (abnormally low blood pressure)
50-59:
- Cardiac disorder
- Cardiomegaly (increased size of heart than normal)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Death
- Depression
- Fear
- Injury
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Organ failure
- Pain
60+:
- Pneumonia
- Depressed level of consciousness
- Cough
- Renal failure acute (rapid kidney dysfunction)
- Spinal osteoarthritis (joint cartilage loss in spine)
- Thrombocytopenia (decrease of platelets in blood)
- Diarrhoea
- Abdominal pain upper
- Anaemia (lack of blood)
- Arthralgia (joint pain)
What are the existing conditions these people have? *
- High Blood Pressure: 33 people, 36.67%
- Pain: 15 people, 16.67%
- Sedation: 9 people, 10.00%
- Pneumonia: 8 people, 8.89%
- Constipation: 8 people, 8.89%
- Stable Angina (a constant chest pain): 7 people, 7.78%
- Multiple Myeloma (cancer of the plasma cells): 7 people, 7.78%
- Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 7 people, 7.78%
- Diabetes: 7 people, 7.78%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 7.78%
* Approximation only. Some reports may have incomplete information.
Do you take Ceftazidime and Nitroglycerin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ceftazidime (10,327 reports)
- Nitroglycerin (52,884 reports)
Browse all drug interactions of Ceftazidime and Nitroglycerin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ceftazidime:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Nitroglycerin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ceftazidime and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nitroglycerin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
- Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ceftazidime and nitroglycerin (the active ingredients of Ceftazidime and Nitroglycerin, respectively), and Ceftazidime and Nitroglycerin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lymecycline cause Death? - 4 seconds ago
- Pain and Acidosis - 6 seconds ago
- Could Lunesta cause Application Site Vesicles? - 17 seconds ago
- Could Celexa cause Tinnitus Aggravated? - 22 seconds ago
- Drug interactions of Concerta and Valacyclovir - 27 seconds ago
- Could Gilenya cause Pneumonia Aggravated? - 35 seconds ago
- Drug interactions of Glyburide and Levemir - 43 seconds ago
- Myasthenia Gravis and Cystitis Aggravated - 44 seconds ago
- Myasthenia Gravis Aggravated and Atrial Fibrillation/Flutter - 46 seconds ago
- Drug interactions of Voltaren and Synthroid - 49 seconds ago